Erick DeVinney

Mr. DeVinney has served as Axogen’s Vice President of Peripheral Nerve Science and Clinical Innovation since June 2021. From January 2014 to May 2021, he was Vice President of Clinical and Translational Sciences, and from April 2007 until January 2014 Mr. DeVinney was the Director of Clinical and Translational Sciences for Axogen. Mr. DeVinney has more than 18 years of experience in the successful planning and management of clinical studies. He has a diverse background, including research at a large academic facility and management of clinical operations for a medical device and pharmaceutical company. Mr. DeVinney has been involved in clinical research at the Medical College of Virginia Hospitals, National Clinical Research, PRA International, and Angiotech. He has been involved in the successful submission of eight IDE or NDA applications, as well as numerous 510(k)s. He has a B.S. degree in Chemistry from Virginia Commonwealth University.